Biotechnology

Monsanto Chesterfield Village Expansion Groundbreaking of Research and Development Center Marks Next Generation for Agriculture and St. Louis

Press Release

ST. LOUIS, October 23, 2013 /3BL Media/ – Monsanto Company hosted an event yesterday to commemorate the beginning of the Chesterfield Village Research Center expansion, its global hub for research and development (R&D) and agricultural innovation.   The $400 million expansion, first announced in April 2013, will create 675 new jobs in St. Louis across all levels over the next three years.

World Food Prize Laureate Robert Fraley: Innovation and Communication Needed to Safely Feed a Growing Population

Monsanto Confirms Commitment to Broader Dialogue on the Role of Innovation in Reducing World Hunger, Protecting the Environment
Press Release

DES MOINES, Iowa, October 17, 2013 /3BL Media/ – Monsanto Chief Technology Officer and World Food Prize laureate Dr. Robert Fraley confirmed Monsanto’s commitment to broader open dialogue to address questions around innovations in agriculture, including biotechnology.

“Innovation is key to feeding a rapidly growing global population while also protecting the environment,” Fraley said. “But better dialogue is needed to build understanding and consensus in addressing some of humanity’s biggest challenges.”   

World Food Prize Laureate Dr. Robert Fraley to Donate Award to Support Advancement of Women in Plant Science

World Food Prize Award to Be Matched by Monsanto and Fraley to Establish Fraley-Borlaug Scholars in Plant Science Scholarship at University of Illinois
Press Release

DES MOINES, Iowa, October 15, 2013 /3BL Media/ -- World Food Prize 2013 laureate Dr. Robert T.

CMAJ: Sanofi BioGENEius Challenge Canada Honors Teenage Health Scientists

Article

By Lauren Kramer, Vancouver, BC

A 16-year-old Calgary, Alberta, student recently earned first place nationwide in the annual Sanofi BioGENEius Challenge Canada, a biotechnology research competition that encourages high school students to pursue future studies and careers in life sciences.

Arjun Nair, a grade 11 student at Calgary’s Webber Academy, conducted research into an experimental cancer treatment that involves injecting patients with nano particles of gold. The particles accumulate in tumours, forming so-called “nano bullets” that can be heated to kill cancer cells.

Monsanto’s Robert T. Fraley Named 2013 World Food Prize Laureate

Press Release

ST. LOUIS, June 19, 2013 /3BL Media/ – At the 2013 World Food Prize Announcement Ceremony held today at the U.S. State Department, Monsanto’s Chief Technology Officer, Robert T. Fraley, Ph.D., was named a 2013 World Food Prize Laureate. Fraley’s recognition is for the research he and his teams pioneered in plant biotechnology and its application to advanced breeding and crop improvement techniques in agriculture.

Fraley will share the prestigious prize with Marc Van Montagu, Ph.D., and Mary-Dell Chilton, Ph.D.

Monsanto’s Integrated Yield Pipeline Advances a Record 18 Projects Across Multiple Research Areas

Press Release

ST. LOUIS, Jan. 9, 2013 /3BL Media/ - Monsanto’s annual research and development update highlighted record project advancement across the company’s breeding, biotechnology, and improved agronomics platforms, all aimed at sustainably maximizing farmer productivity while conserving resources like water and land.

Monsanto Company Provides Royalty-Free Access To Important Biotechnology Innovation For Academic Research Community And Non-Profit Research Institutions

Press Release

(3BL Media) St. Louis, MO - Sept. 25, 2012 - Monsanto Company today announced that it will provide a royalty-free research license to the academic community and other non-profit research institutions to a newly issued US Patent related to the Agrobacterium transformation method.

Unprecedented Donation by Korean Stem Cell Leader: Dr. Jeong-Chan Ra of RNL Bio announces the donation of 90% of his wealth

Stressing the "importance of corporate responsibility," Dr. Ra's donations will advance social institutions dedicated to helping patients with retractable diseases
Press Release

SEOUL, South Korea, Sept. 8, 2012 / 3BL Media /PRNewswire/ -- Dr. Jeong-Chan Ra, founder and largest shareholder of RNL Bio (www.rnl.co.kr), an international biotechnology research and development firm, has pledged to give away 90% of his personal wealth over the next 10 years to promote social causes consistent with the values of human life.  Dr. Ra will donate 90% privately owned equity, equity-related bonds, warrants and other assets of RNL Bio Co.

Pages

Subscribe to Biotechnology